Zimmer Biomet Holdings, Inc. (ZBH) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Devices Branche. Der Hauptsitz des Unternehmens ist in Warsaw, IN, United States. Der aktuelle CEO ist Ivan Tornos.
ZBH hat IPO-Datum 2001-07-25, 17,000 Vollzeitbeschäftigte, gelistet an der NYSE, eine Marktkapitalisierung von $18.88B.
Zimmer Biomet Holdings, Inc. is a global musculoskeletal healthcare company that designs, manufactures, and markets a comprehensive portfolio of medical devices and surgical solutions. The company's core offerings include orthopaedic reconstructive products for knees and hips, spine devices, sports medicine and trauma products, dental implants and regenerative solutions, as well as robotic-assisted surgical systems and bone cement products. Zimmer Biomet serves orthopedic surgeons, neurosurgeons, dentists, hospitals, and healthcare systems across the Americas, Europe, the Middle East, Africa, and Asia Pacific. Founded in 1927 and headquartered in Warsaw, Indiana, the company addresses treatment needs for patients with bone, joint, and soft tissue disorders through innovative surgical and therapeutic solutions.
